Evidence map›Paper›PMID 32954301›Full record

ArticleBrain communications2020

Activity or connectivity? A randomized controlled feasibility study evaluating neurofeedback training in Huntington's disease.

Marina Papoutsi, Joerg Magerkurth, Oliver Josephs, Sophia E Pépés, Temi Ibitoye, Ralf Reilmann, Nigel Hunt, Edwin Payne, Nikolaus Weiskopf, Douglas Langbehn and 2 more

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. From lab to life: challenges and perspectives of fNIRS for haemodynamic-based neurofeedback in real-world environments.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Marina PapoutsiUCL Huntington's Disease Centre, Queen Square Institute of Neurology, University College London, London WC1B 5EH, UK.ORCID 0000-0003-0971-8361
Joerg MagerkurthBirkbeck-UCL Centre for Neuroimaging, University College London, London WC1H 0AP, UK.
Oliver JosephsWellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, University College London, London WC1N 3AR, UK.
Sophia E PépésUniversity of Oxford, Harris Manchester College, Oxford OX1 3TD, UK.
Temi IbitoyeUCL Huntington's Disease Centre, Queen Square Institute of Neurology, University College London, London WC1B 5EH, UK.
Ralf ReilmannGeorge Huntington Institute, 48149 Münster, Germany.
Nigel HuntEastman Dental Institute, University College London, London WC1X 8LD, UK.
Edwin PayneEastman Dental Institute, University College London, London WC1X 8LD, UK.
Nikolaus WeiskopfWellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, University College London, London WC1N 3AR, UK.
Douglas LangbehnCarver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Geraint ReesWellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, University College London, London WC1N 3AR, UK.
Sarah J TabriziUCL Huntington's Disease Centre, Queen Square Institute of Neurology, University College London, London WC1B 5EH, UK.
University College London · GBWellcome Centre for Human Neuroimaging · GBEastman Dental Hospital · GBUK Dementia Research Institute · GBUniversity of Iowa · USUniversity of Münster · DEUniversity of Oxford · GB

Funding

Medical Research Council MR/L012936/1Wellcome Trust
6 · The paper itself

Abstract

Non-invasive methods, such as neurofeedback training, could support cognitive symptom management in Huntington's disease by targeting brain regions whose function is impaired. The aim of our single-blind, sham-controlled study was to collect rigorous evidence regarding the feasibility of neurofeedback training in Huntington's disease by examining two different methods, activity and connectivity real-time functional MRI neurofeedback training. Thirty-two Huntington's disease gene-carriers completed 16 runs of neurofeedback training, using an optimized real-time functional MRI protocol. Participants were randomized into four groups, two treatment groups, one receiving neurofeedback derived from the activity of the supplementary motor area, and another receiving neurofeedback based on the correlation of supplementary motor area and left striatum activity (connectivity neurofeedback training), and two sham control groups, matched to each of the treatment groups. We examined differences between the groups during neurofeedback training sessions and after training at follow-up sessions. Transfer of training was measured by measuring the participants' ability to upregulate neurofeedback training target levels without feedback (near transfer), as well as by examining change in objective, a priori defined, behavioural measures of cognitive and psychomotor function (far transfer) before and at 2 months after training. We found that the treatment group had significantly higher neurofeedback training target levels during the training sessions compared to the control group. However, we did not find robust evidence of better transfer in the treatment group compared to controls, or a difference between the two neurofeedback training methods. We also did not find evidence in support of a relationship between change in cognitive and psychomotor function and learning success. We conclude that although there is evidence that neurofeedback training can be used to guide participants to regulate the activity and connectivity of specific regions in the brain, evidence regarding transfer of learning and clinical benefit was not robust.

Indexed as

Huntington’s diseaseneurofeedback trainingneuroplasticityreal-time fMRI

Identifiers

PMID32954301
PMCPMC7425518
OpenAlexW3018457323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.